Conversely, β value > 1, with the 95% CI excluding 1, reflects a wear-out failure pattern, where the risk of AEs increases over time, indicating a significant trend of rising risk with extended treatment duration.
← all excerpts
A pharmacovigilance study of vortioxetine based on data from the FDA adverse event reporting system.
1
—
—